Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programmePositive results show that the average weight loss was 12.5 kg (11.8 ...

We examine the labor market effects of AI chatbots using two large-scale adoption surveys (late 2023 and 2024) covering 11 exposed occupations (25,000 workers, 7,000 workplaces), linked to matched ...

Spice level is a subjective matter, but some foods can be hot enough to make an entire country ponder on their legality. Such ...

Microdosing weight loss drugs, a growing global trend, could offer a new gateway solution for obesity for those priced out of ...

A groundbreaking study reveals that 50% of adults using GLP-1 receptor agonists for weight loss quit within a year. Financial ...

For almost three months, Sunil (name changed) has been taking an injection on his abdomen for weight-loss. He has lost 10kg of his initial 90k.

People on weight loss medications such as Ozempic and Wegovy were more likely to stop taking the drugs if they were younger, ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...

"For them to work effectively, they need to be taken long term," cautioned epidemiologisy professor Reimar W. Thomsen.